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P4-ATPases are lipid ﬂippases that transport phospholipids across cellular membranes, playing vital
roles in cell function. In humans, the disruption of the P4-ATPase ATP8A2 gene causes a severe
neurological phenotype. Here, we found that Atp8a2 mRNA was highly expressed in PC12 cells,
hippocampal neurons and the brain. Overexpression of ATP8A2 increased the length of neurite out-
growth in NGF-induced PC12 cells and in primary cultures of rat hippocampal neurons. Inducing
the loss of function of CDC50A in hippocampal neurons via RNA interference reduced neurite
outgrowth, and the co-overexpression of CDC50A and ATP8A2 in PC12 cells enhanced NGF-induced
neurite outgrowth. These results indicate that ATP8A2, acting in synergy with CDC50A, performs an
important role in neurite outgrowth in neurons.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The asymmetric distribution of phospholipids within the plas-
ma membrane is a fundamental feature of eukaryotic cells [1]. In
animal cells, phosphatidylcholine (PC) and sphingolipids are local-
ized in the exoplasmic leaﬂet of the plasma membrane, while
phosphatidylserine (PS) and phosphatidylethanolamine (PE) are
limited to the cytoplasmic leaﬂet [2]. Maintenance of phospholipid
asymmetry has been demonstrated to play a role in various cellular
activities, such as cell signaling, cytokinesis, vesicle transport,
blood clotting, clearance of apoptotic cells, host-viral interactions,
liver lipid metabolism and B lymphopoiesis [3,4].
The maintenance and regulation of membrane lipid asymmetry
are governed by ATP-driven ﬂippases/ﬂoppases that transport spe-
ciﬁc lipids against a concentration gradient across the bilayer.
Studies in yeast have revealed that members of the type 4 subfam-
ily of the P-type ATPase superfamily (P4-ATPase) known as ﬂippas-
es are responsible for the translocation of speciﬁc phospholipids
from the exoplasmic to the cytoplasmic leaﬂet of membrane [4].
However, the physiological functions of most mammalian P4-ATP-
ases are largely unclear. At least one human disease, familial intra-
hepatic cholestasis type 1 (FIC1) [5], has been reported to be
associated with ATP8B1, a member of the P4-ATPase gene family.
Sequence analysis indicated that ATP8B1 is homologous to achemical Societies. Published by E
.shcnc.ac.cn (X. Ding).Saccharomyces cerevisiae ortholog, Drs2p, which is a trans-Golgi-
localized integral membrane protein. Drs2p is necessary and
sufﬁcient to translocate PS to the cytosolic leaﬂet of the trans-Golgi
network (TGN). This protein also plays a vital role in membrane
trafﬁcking from the TGN to the early endosome and to the later
endosome or vacuole [6]. Loss of Drs2p and Dnf3p function in yeast
disrupts aminophospholipid transport and membrane lipid asym-
metry, causing failure of post-Golgi secretory vesicle formation [3].
Despite the cumulative data about the detailed function of ﬂip-
pase molecules, evidence indicating the relationship of human dis-
eases with malfunction of ﬂippase genes is still rare. It was recently
reported that disruption of the ATP8A2 gene, another P4-ATPase, is
associated with a severe neurological phenotype in a patient with
mental retardation [7]. The chromosome translocation identiﬁed in
this patient disrupts a single candidate gene (ATP8A2) that is
highly expressed in the brain. This case suggests that ATP8A2
mutations may be associated with diseases of mammalian nervous
systems. Studies in photoreceptor disc membranes also support
the role of ATP8A2 in the generation and maintenance of phospho-
lipid asymmetry [8]. Indeed, many P4-ATPases are abundantly
expressed in the brain [9], with Atp8a2 being found in the hippo-
campal region (See Allen Brain Atlas Resources: http://www.
brain-map.org). Thus, it is worth investigating the role of ATP8A2
in mammalian neuronal differentiation.
Studies in S. cerevisiae have revealed that P4-ATPases interact
with members of the Cdc50p/Lem3p family [10]. For example,
the yeast P4-ATPase Drs2p requires Cdc50p for phosphorylationlsevier B.V. All rights reserved.
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catalytic reaction [11]. Furthermore, it is clear that a P4-ATPase-
CDC50 protein physical interaction is critical for the release of
the P4-ATPase from the endoplasmic reticulum (ER) [12]. Three
CDC50 proteins (CDC50A, B and C) are expressed in mammalian
cells [13]. ATP8A2 travels from the ER to the Golgi complex and
reaches the plasma membrane upon co-expression of CDC50A,
but not CDC50B [14]. In another recent study, CDC50A was ob-
served to function as a subunit of ATP8A2 and to be crucial for
the correct folding, stable expression, export from the ER and PS
ﬂippase activity of ATP8A2 [15]. However, whether all P4-ATPases
require CDC50 proteins for their function and how speciﬁc P4-ATP-
ases interact with CDC50 proteins in mammalian cells is presently
unclear.
In the present work, we investigated the role of ATP8A2 during
neuronal differentiation in PC12 cells, derived from a rat adrenal
medulla pheochromocytoma, and in rat hippocampal neurons.
Also, for the ﬁrst time, we concluded that ATP8A2, acting in syn-
ergy with CDC50A, plays a vital role in neurite outgrowth of
neurons.2. Materials and methods
2.1. Reagents and antibodies
Recombinant human nerve growth factor was purchased from
CALBIOCHEM (San Diego, CA), and epidermal growth factor (EGF)
was purchased from R&D Systems (Minneapolis, MN). A rabbit
polyclonal HA-probe (Y-11) antibody was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal antibodies
against Myc, FLAG and b-actin were obtained from Sigma–Aldrich
(Saint Louis, MO).
2.2. Cell culture and transfection
The cell lines used in this work were obtained from ATCC
(Manassas, VA). PC12 cells were cultured in a 1:1 mixture of
DMEM and Ham’s F12 (DF-12) medium supplemented with 5%
fetal bovine serum, 5% horse serum, 1% glutamine and 1% non-
essential amino acids (NEAA) at 37 C in a 5% CO2 atmosphere.
The primary culture of hippocampal neurons employed in these
experiments was isolated from E18 rat embryos, as described pre-
viously [16]. The transfection was performed using the Amaxa
Nucleofection™ system (Amaxa, Gaithersburg, MD) and pmaxGFP
(0.5 lg/ul in 10 mM Tris, pH 8.0), which encodes green ﬂuorescent
protein (GFP), was used as a reporter. The pmaxGFP-expressing
cells were analyzed by ﬂuorescence microscopy to monitor the
transfection efﬁciency. Only cells with transfection efﬁciency high-
er than 90% were used for further experiments.
2.3. Generation of constructs
An HA-tagged Atp8a2 plasmid was created by ligating the open
reading frame sequence of Atp8a2 into pcDNA3-HA between the
EcoRI and XhoI sites with a C-terminal HA tag. The open reading
frame of mouse Cdc50a was subcloned into pcDNA3.1 with an N-
terminal Myc tag. Scrambled RNA for use as control short hairpin
RNA (shRNA) was purchased from Santa Cruz Biotechnology. To
silence ATP8A2 or CDC50A expression, three shRNA-expressing
plasmids were generated using the pSIREN-retroQ vector (Clontech
Laboratories Inc., Palo Alto, CA). The plasmid containing the
target sequence 50-ATGGCATGTGGCACACTAT-30 efﬁciently knocked
down Atp8a2, while the sequence 50-GAGCTATTGCCAACAGCAT-30
resulted in efﬁcient knockdown of Cdc50a. A catalytically dead
mutant of ATP8A2 was generated by replacing its aspartate (D)residue with alanine (A) using the Quikchange Site-directed Muta-
genesis kit (Stratagene, La Jolla, CA). The optimal primers for PCR
ampliﬁcation of Atp8a2-D388A are as follows: forward primer,
50-ACCTGTTTTCAGCCAAGACTGGAAC-30; reverse primer, 50-GTTCC
AGTCTTGGCTGAAAACAGGT-30.
2.4. Western blotting, immunoﬂuorescence staining and confocal
microscopy
To detect the expression levels of HA-tagged Atp8a2 or Myc-
tagged Cdc50a, PC12 cells treated as indicated were lysed in
200 ll of lysis buffer and subjected to Western blotting analysis
[17]. To show the relative protein level, Tanon Gis (Gel image sys-
tem) was used to collect the Gray-Scale of the protein bands. As
previously described [18], PC12 cells and hippocampal neurons
grown on coverslips were stained with appropriate primary anti-
bodies followed by Cy2-conjugated anti-mouse IgG or Cy3-conju-
gated anti-rabbit IgG (Jackson ImmunoResearch, West Baltimore,
PA). The coverslips were subsequently mounted and examined
using a Nikon Neurolucida system or a Zeiss confocal microscope.
2.5. RNA extraction and reverse transcription
Total RNA isolation and reverse transcription were performed
as previously described [19]. The intensity of each ampliﬁed band
was measured and normalized to the corresponding glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) content value. ATP8A2
cDNA was ampliﬁed using primers based on the mouse nucleotide
sequence information (GenBank accession number NM_015803).
The optimal primers designed for PCR are as follows: GAPDH - for-
ward primer, 50-CGGAGTCAACGGATTTGGTCGTAT-30and reverse
primer, 50-AGCCTTCTCCATGGTGGTGAAGAC-30; ATP8A2 - forward
primer, 50-CTTCTGTCGGATGACTTCTTG-30 and reverse primer, 50-
TGTTCTTGTCCCATCGCTTC-30; Cdc50a forward primer, 50-TACACCC
AACATTACCAG-30 and reverse primer, 50-CAGTAGACGCATTTCATA
G-30; Cdc50b - forward primer, 50-ATGGCTTACCGACTTGAC-30 and
reverse primer, 50-CAGACTGCTCTTGCGTTT-30; and Cdc50c - for-
ward primer, 50-TCTCTTCCTTTTTACCTTCC-30 and reverse primer,
50-CATACTTATCTGTCCACCAT-30. The primers were synthesized by
Sangon Biotech (Shanghai, China). Ex Taq polymerase (Takara
Shuzo, Kyoto, Japan) was used for ampliﬁcation and the primers
were annealed at 58 C. The obtained PCR products were visualized
using ethidium bromide on 1% agarose gels.
2.6. Neurite outgrowth analysis
Neurite outgrowth length was measured using the manual
image analysis tools included in Image-Pro Plus (IPP) 5.1 (Media
Cybernetics, Atlanta, GA) according to the manufacturer’s instruc-
tions. Cells possessing one or more neurites longer than 1.5-times
the diameter of the cell bodies were scored as positive. The neurite
growth length (NGL) was obtained by measuring the neurite
length. The NGL was calculated by dividing the sum of the calcu-
lated neurite length by the diameter of the cell body and was used
to measure neurite length in this work [20]. For each experiment,
at least 30 cells were randomly selected for measurement. Neuro-
nal morphology was analyzed within 72 h after plating to avoid
dendritic arborization at late culture stages [21].
2.7. Statistical analysis
All assays were performed in triplicate. In each assay, the
data are presented as the means ± standard error (S.E.), with n
representing the number of different experiments. Comparison
of the data was performed using Student’s t-test and an analysis
of variance (ANOVA). Pearson’s correlation was used to analyze
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ered statistically signiﬁcant at ⁄⁄⁄P < 0.001 and ⁄⁄P < 0.01. For all
analyses, a two-sided p value < 0.05 was considered to indicate
statistical signiﬁcance. The errors bars in the graphs represent
S.E.M.
3. Results
3.1. NGF-induced neurite outgrowth in PC12 cells is enhanced by
ATP8A2 overexpression
To investigate the role of ATP8A2 in mammalian neuronal dif-
ferentiation, we ﬁrst conﬁrmed the expression proﬁle of Atp8a2
in various tissues in adult mice via RT-PCR. As shown in Fig. 1A,
Atp8a2mRNA was clearly detectable in the brain, testis and epidid-
ymis, but not in other tissues, such as the heart, lung, kidney, mus-
cle or liver. This is in accordance with the previously reported
Atp8a2 expression proﬁle [9]. When induced by NGF, PC12 cells
cease proliferation and differentiate into neuron-like cells showing
a neuronal morphology and gene expression proﬁle [22]. This fea-
ture has resulted in PC12 cells becoming a widely used cell line for
studying neuronal differentiation. Atp8a2 mRNA was highly
expressed in PC12 cells, but not in other mammalian cell lines
such as HEK 293T cells, NIH 3T3 cells, and CHO cells (Fig. 1B),
suggesting that ATP8A2 may have functional relevance for neuro-
nal differentiation.
In response to NGF, PC12 cells produce long neurite-like protru-
sions: the cells cease to proliferate and begin to undergo branching,
similar to sympathetic neurons in primary cell culture [23]. After
2 days of treatment with NGF, extended neurites were easily iden-
tiﬁed in PC12 cells. To address whether ATP8A2 plays a role in neu-
ronal differentiation, we overexpressed ATP8A2 in PC12 cells,
followed by NGF treatment (48 h, 50 lg/ml) [24]. We found that
longer neurites were extended from cells transfected with Atp8a2
compared to non-transfected PC12 cells (Fig. 1C). To quantify the
length of the growing neurites, we deﬁned the neurite growth
length (NGL) as reﬂecting the length of neurites in each culture
and analyzed the results using IPP 5.1 (see Section 2). Atp8a2-trans-
fected PC12 cells produced much longer neurites than untransfec-
ted cells following NGF induction (Fig. 1D) (⁄⁄P < 0.01). The NGL
scorewas approximately 5 in Atp8a2-transfected PC12 cell, whereas
it was only approximately 3 in the untransfected cells. Measure-
ment of the diameter of NGF-induced cell bodies indicated that
the mean cell body size of transfected cells was not signiﬁcantly
different from that of untransfected cells (Fig. 1E). Themean branch
number per cell, a parameter related to the initiation of neurite out-
growth, was unchanged in transfected PC12 cells (Fig. 1F), showing
that ATP8A2 overexpression did not interfere with the initiation
process but did affect the elongation process involved in neurite
outgrowth. In addition, a time course analysis of NGL showed that
ATP8A2 overexpression signiﬁcantly increases the length of
neurites, indicating that ATP8A2 enhances neurite outgrowth in
NGF-treated PC12 cells (Fig. 1G) (⁄⁄P < 0.01).
3.2. Atp8a2 shRNA reduces Atp8a2 expression and impairs neurite
outgrowth
We used shRNA to conﬁrm that neurite outgrowth requires
ATP8A2. We designed an Atp8a2 shRNA construct and checked its
efﬁciency via co-transfection of Atp8a2 shRNA and HA-tagged
Atp8a2 plasmids into HEK 293T cells. Atp8a2 shRNA was observed
to strongly impair Atp8a2 mRNA expression in HEK 293T cells
(Fig. 2A). Likewise, when Atp8a2 shRNA and HA-tagged Atp8a2
plasmids were co-transfected into PC12 cells, the protein level of
ATP8A2 was reduced (Fig. 2B and C), and consequently, a reductionof the neurite outgrowth was observed (Fig. 2D). The NGL in co-
transfected cells clearly declined compared with cells transfected
with Atp8a2 alone (⁄⁄P < 0.01) (Fig. 2E). However, the cell body size
and neurite branch number were unchanged following the trans-
fection of Atp8a2 shRNA alone (data not shown), indicating that
the increase in NGF-induced neurite outgrowth is associated with
ATP8A2. Interestingly, when we transfected only Atp8a2 shRNA
into PC12 cells, we also observed a decline in the NGL (Fig. 2D
and E). Because PC12 cells express Atp8a2, this result strongly sug-
gests that endogenous ATP8A2 is involved in the NGF-induced
neurite outgrowth observed in PC12 cells.
3.3. The increment of neurite length is associated with ATP8A2
catalytic activity
To conﬁrm that the increase in neurite length in Atp8a2-trans-
fected PC12 cells is associated with the catalytic activity of
ATP8A2, we mutagenized ATP8A2 by replacing the aspartate res-
idue (D at position 388) in the sequence DKTGTLT with alanine
(A). This residue, which is conserved in all P-type pumps, is tran-
siently phosphorylated during its catalytic cycle [25]. Hence, any
mutation of this aspartate residue abolishes enzyme activity.
We transfected PC12 cells with Atp8a2-D388A (Fig. 3A–C) and
measured the neurite length produced under NGF treatment.
Compared to ATP8A2-transfected cells, ATP8A2-D388A overex-
pression did not enhance NGF-induced neurite outgrowth in
PC12 cells (Fig. 3D) (⁄⁄P < 0.01); the NGL in these cells was nearly
the same as that in untransfected cells (Fig. 3E). There were no
differences in the cell body size or the branch number between
Atp8a2-D388A-transfected cells and Atp8a2-transfected cells or
between Atp8a2-D388A-transfected cells and untransfected cells
(data not shown). Thus, the increase in NGL in ATP8A2-over-
expressing cells is due to its catalytic activity of this enzyme,
strongly supporting the idea that ATP8A2 is required for NGF-
induced neurite outgrowth.
3.4. Overexpression of ATP8A2 increases axon length in rat
hippocampal neurons
Newborn rat hippocampal cells differentiate into neurons when
they are isolated and cultured in vitro. Within one week of culture,
the cells begin to differentiate and form several, apparently identi-
cal, short processes. Then, one of the short processes grows very
rapidly to become an axon, while the remaining processes become
dendrites [26]. Based on the observation that ATP8A2 increases
neurite outgrowth in NGF-treated PC12 cells, we next asked
whether ATP8A2 functions similarly in hippocampal neuron differ-
entiation. Atp8a2mRNA was clearly detectable in hippocampal tis-
sues (Fig. 4A). We transfected the Atp8a2 plasmid together with the
ﬂuorescence marker RFP as a tracer into primary cultures of hippo-
campal cells. On the second day of culture (2 days in vitro [DIV]),
axons, which are the fastest growing protrusions, were easily
identiﬁed.
Analysis of the length of RFP-positive axons revealed that the
axon length in hippocampal neurons transfected with Atp8a2
was longer than that in control cells (Fig. 4B), being increased
by approximately 1.6 times compared with RFP transfection
alone (⁄⁄P < 0.01) (Fig. 4C). This increase was not observed in
neurons transfected with Atp8a2-D388A alone and was decreased
by co-transfection of shRNA (data not shown). When only Atp8a2
shRNA was transfected, the resultant axon length was apparently
shorter than observed in untransfected hippocampal neurons,
strongly supporting the idea that ATP8A2 plays a pivotal role
in promoting axon growth during rat hippocampal neuronal
differentiation.
Fig. 1. NGF-induced neurite outgrowth in PC12 cells is enhanced by ATP8A2 overexpression. Atp8a2 expression was analyzed by RT-PCR. GAPDH was used as a loading
control. (A) In adult mice, Atp8a2 mRNA was expressed in the testis, brain and epididymis. (B) Atp8a2 mRNA was expressed in PC12 cells, but not in HEK 293T cells, NIH 3T3
cells, or CHO cells. (C) PC12 cells transfected with Atp8a2 generated neurites that were much longer than those of untransfected cells. (D) To quantify the outgrowth rate of
the neurites, 30 PC12 cells were randomly selected in each experiment, and the total length of the branches was divided by the total cell body diameter to obtain the neurite
growth length (NGL). The NGL in Atp8a2-transfected PC12 cells increased signiﬁcantly compared with that in untransfected cells (⁄⁄P < 0.01, compared with control, n = 30).
(E) NGF treatment increased the average diameter of the cell body by approximately 30%; ATP8A2 transfection had no effect on this parameter (⁄⁄P < 0.01, compared with
NGF-induced cells, n = 30). (F) The average branch number for each PC12 cell remained unchanged when ATP8A2 was overexpressed. NGF treatment: 50 ng/ml for 48 h. Scale
bar: 100 lm. (G) Time course analysis of NGL in NGF-induced PC12 cells. ATP8A2 overexpression signiﬁcantly increases the length of neurites (Student’s t-test, ⁄⁄P < 0.01,
compared with control, n = 3). The green circle indicated the control cells and the blue square indicated the Atp8a2-transfected cells.
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Fig. 2. Atp8a2 shRNA reduces ATP8A2 expression and impairs neurite outgrowth in PC12 cells. (A) Atp8a2mRNA expression was strongly reduced when HEK 293T cells were
co-transfected with Atp8a2 shRNA. (B) Western blot analysis of PC12 cells co-transfected with Atp8a2 and Atp8a2 shRNA and treated with NGF (50 ng/ml). ATP8A2 protein
expression was reduced. (C) The levels of ATP8A2 were quantiﬁed and shown as relative protein level. (D) While co-transfection of Atp8a2 and Atp8a2 shRNA abolished the
enhanced elongation of neuronal outgrowth in PC12 cells, transfection of Atp8a2 shRNA alone also reduced neuronal outgrowth. (E) Statistical calculation of the NGL in PC12
cells shown in C (⁄⁄P < 0.01, compared with Atp8a2 shRNA, n = 30). Scale bars: 100 lm.
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differentiation
To explore the functional relationship of the CDC50 protein
family with ATP8A2 during neuronal differentiation, we analyzed
CDC50 (Cdc50a, b and c) expression using gene-speciﬁc primers.
Only Cdc50a mRNA was observed to be highly expressed in cul-
tured hippocampal neurons. Cdc50b and Cdc50c mRNA were unde-
tectable (Fig. 5A), indicating that CDC50A may participate in the
process by which ATP8A2 increases the axon length in hippocam-
pal neurons.
We also designed a Cdc50a shRNA construct and checked its efﬁ-
ciency (Fig. 5B–D). Transfection of Atp8a2 into hippocampal neu-
rons increased axon length by approximately 1.6 times compared
to untransfected cells (Fig. 4C). To address whether Cdc50a is in-
volved in this process, we co-transfected Atp8a2 and Cdc50a shRNA
plasmids into hippocampal neurons and found that the increase in
axon length could indeed be abolished (Fig. 5E and F). Furthermore,
we observed that Cdc50a shRNA transfection alone could greatly de-
crease axon length (⁄⁄P < 0.01) (Fig. 5F), indicating that endogenous
CDC50A participates in the axon elongation process. Cdc50a shRNA
reduced the average axon length to approximately 70% of that incontrol cells, whereas the control shRNA had no effect (Fig. 5E and
F). However, when we overexpressed CDC50A in hippocampal neu-
rons, we did not detect an increase in neurite length (Fig. 5F).
Taken together, these ﬁndings show that CDC50A deﬁciency in
hippocampal neurons reduces axon length, indicating that CDC50A
is involved in neuronal differentiation. These results, together with
the data presented above, provide evidence that CDC50A acts in
synergy with ATP8A2 to promote axon elongation during rat hip-
pocampal neuronal differentiation.
3.6. Co-expression of Atp8a2 and Cdc50a increases neurite outgrowth
length in PC12 cells
Based on the function of CDC50A observed in hippocampal neu-
rons, we analyzed the function of CDC50A in PC12 cells. We did not
detect Cdc50a expression in the PC12 cells, although different pairs
of primers were used (Fig. 5A). When we co-transfected Atp8a2 and
Cdc50a plasmids into PC12 cells and treated the cells with NGF for
an additional 48 h (50 ng/ml), increased neurite outgrowth was
observed (Fig. 6A) (⁄⁄P < 0.01). Both the NGL (Fig. 6B) and the length
of the longest neurite (Fig. 6C) of the PC12 cells were measured. Co-
overexpression of Atp8a2 and Cdc50a plasmids slightly increased
Fig. 3. ATP8A2 catalytic activity is associated with the increased neurite outgrowth in PC12 cells. (A) Sequence alignment of ATP8A2, ATP8B5 (FetA) and Drs2p. Identical
residues critical for catalytic activity are marked with an asterisk (⁄). (B) Western blot analysis of PC12 cells transfected with Atp8a2-D388A. (C) The levels of ATP8A2/ATP8A2-
D388A were quantiﬁed and shown as relative protein level. (D) The catalytically dead mutant ATP8A2-D388A, in which the position 388 aspartic acid is replaced with alanine,
had no effect on the enhancement of neuronal outgrowth in PC12 cells. (E) Statistical calculation of the NGL in PC12 cells is shown in B (⁄⁄P < 0.01, compared with Atp8a2,
n = 30). The NGL was the same in Atp8a2-D388A-transfected and untransfected PC12 cells. NGF treatment at 50 ng/ml for 48 h; Scale bars: 100 lm.
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pared to Atp8a2 transfection alone (⁄P < 0.05) (Fig. 6B and C). How-
ever, we did not detect any changes in theNGL or the longest neurite
length in cells overexpressing CDC50A alone. Collectively, these
data show that the co-overexpression of ATP8A2 and CDC50A en-
hanced the neurite outgrowth length in the PC12 cells and that
CDC50A was also involved in the function of ATP8A2 in the PC12
cells.4. Discussion
Several lines of evidence suggest that ATP8A2, a member of the
P4-ATPase family, plays a role in neuronal differentiation. Disrup-
tion of the ATP8A2 gene in a patient caused a severe neurological
phenotype [7], suggesting that ATP8A2may play some role inmam-
malian neural system diseases. Research ﬁndings also support the
role of ATP8A2 in the generation and maintenance of phospholipid
Fig. 4. ATP8A2 increases the length of the axon in hippocampal neurons. Newborn rat hippocampal cells were isolated and cultured in vitro. One of the short processes grew
very rapidly and became an axon, which was easily identiﬁed, while the others became dendrites. (A) Atp8a2mRNA was expressed in cultured hippocampal neurons (HP). (B)
Overexpression of ATP8A2 in cultured hippocampal neurons increased the length of axons, while transfection of Atp8a2 shRNA apparently reduced the elongation of
hippocampal axons. The catalytically dead mutant ATP8A2 had a much weaker effect compared to wild-type ATP8A2. In each experiment, RFP and Atp8a2 plasmids were co-
transfected (at a ratio of 1:4), and neurons showing red ﬂuorescence were selected for analysis. Transfection of RFP alone served as the control. (C) Statistical calculation of the
axon length in hippocampal neurons shown in B (⁄⁄P < 0.01, compared with control, n = 30). DIV2 means 2 days in vitro. Scale bar: 50 lm.
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of ATP8A2 in neuronal differentiation remains unclear.
In this study, we show that Atp8a2mRNA is expressed in the mouse
brain, PC12 cells and rat hippocampal neurons (Fig. 1 and Fig. 4A).
To obtain insight into the function of ATP8A2, we increased/de-
creased Atp8a2 gene expression in PC12 cells and in primary cul-
tures of hippocampal neurons. We used the NGL to illustrate the
effect of ATP8A2 because evaluating neurite outgrowth in PC12 cells
provides a measure of early events in nervous system differentia-
tion following NGF stimulation. Neurite outgrowth in NGF-induced
PC12 cells was enhanced by ATP8A2 overexpression and was im-
paired by Atp8a2-speciﬁc shRNA. The results from primary cultures
of hippocampal neurons further supported this observation. These
data provide evidence that ATP8A2 plays a vital role in neurite out-
growth during the neuronal differentiation process.
It has been revealed that CDC50 proteins are non-catalytic
accessory proteins for P4-ATPases that play a critical role in P4-ATP-
ase transport activity [10]. In S. cerevisiae, Drs2p requires Cdc50p to
participate in the ATPase reaction cycle. However, in all organisms
in which both gene families have been described, the number
of CDC50 proteins is lower than the number of P4-ATPases. In
humans, three CDC50 homologues and fourteen P4-ATPase genes
have been identiﬁed [9]. Thus, whether CDC50 protein(s) partici-
pate in ATP8A2 activity in all types of mammalian cells and
whether there is any speciﬁcity in ATP8A2-CDC50A interactions
remain unclear.
Here, we report that Cdc50amRNA is preferentially expressed in
hippocampal neurons (Fig. 5A). When Cdc50a was downregulated,neurite elongation was clearly reduced in primary cultured hippo-
campal neurons. While ATP8A2 overexpression increased neurite
length, this effect was strongly impaired when Cdc50a shRNA was
co-expressed. Additionally, co-expressing ATP8A2 and CDC50A in
PC12 cells strongly increased neurite length compared to Atp8a2
transfection alone. Thus, we conclude that CDC50A acts in synergy
with ATP8A2 to enhance the elongation of neurites during hippo-
campal neuronal differentiation. Similarly, van der Velden et al.
recently showed that CDC50A interacts with ATP8A2 in U2OS
cells [14]. Furthermore, our preliminary data indicated partial
subcellular co-localization of ATP8A2 and CDC50A when we co-
overexpressed ATP8A2 and CDC50A in PC12 cells (data not shown).
ATP8A2 was found to be partially localized in intracellular vesicle
membranes via immunoﬂuorescence (Fig. S1). However, there
remain some questions to be answered: could the fact that transfec-
tion of Cdc50a alone in hippocampal neurons did not increase neu-
rite outgrowth be explained as due to the limited expression of
ATP8A2 (Fig. 5)?Why no Cdc50 family (a, b and c) mRNA is detected
in PC12 cells although various primers were tested? Could it be
explained that PC12 is a cell line derived from a pheochromocytoma
of rat adrenal medulla and thus harbored somemutations on Cdc50
genes? More detailed investigation is required to understand how
CDC50 proteins act together with ATP8A2 during different cell
differentiation process.
Neurite outgrowth is a fundamental process during neuronal
differentiation in which intracellular vesicles are involved in mem-
brane addition and protein trafﬁcking [27]. It has been shown that
active vesicle trafﬁcking and turnover in developing neurons lead
Fig. 5. CDC50A is involved in theeffect ofATP8A2onneuriteoutgrowth in thehippocampalneurons. (A)TheexpressionofCdc50mRNAwasexamined inculturedhippocampalneurons
viaRT-PCR.OnlyCdc50a, andnotCdc50borCdc50c,mRNAwasdetected. (B)Cdc50amRNAexpressionwasstronglyreducedwhenHEK293Tcellswereco-transfectedwithCdc50a shRNA.
(C)Westernblot analysisofPC12cells co-transfectedwithCdc50aandCdc50a shRNAandtreatedwithNGF (50 ng/ml). CDC50Aproteinexpressionwas reduced. (D)The levels ofCDC50A
were quantiﬁed and shown as relative protein level. (E) Either Cdc50a or Cdc50a shRNA was co-transfected with RFP (at a ratio of 1:4) into hippocampal neurons for 2 days, and RFP-
positive neuronswere examined todetermine their axon length.While overexpressingCDC50Adidnot signiﬁcantly increase the length of axons, knockdownofCDC50Adecreased their
length. Control shRNA had no effect. (F) Statistical calculation of the length of axons in hippocampal neurons is shown in B (⁄⁄P < 0.01, comparedwith control, n = 30). Scale bar: 50 lm.
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Fig. 6. CDC50A is also involved in the function of ATP8A2 in increasing the length of the longest neurite and NGL score in PC12 cells. (A) Morphology of PC12 cells co-
transfected with Atp8a2 and Cdc50a were treated with NGF (50 ng/ml) for 48 h. (B) We focused on the NGL of PC12 cells. The NGL increased when cells were co-transfected
with Atp8a2 and Cdc50a after being treated with NGF for 48 h (⁄⁄P < 0.01, compared with control, n = 30). (C) The longest neurite length in the PC12 cells increased when they
were co-transfected with Atp8a2 and Cdc50a compared with the control (⁄⁄⁄P < 0.001, compared with control, n = 30). Scale bar: 100 lm.
Q. Xu et al. / FEBS Letters 586 (2012) 1803–1812 1811to the construction of new synaptic sites [28]. Tetanus neurotoxin
insensitive-vesicle associated membrane protein (TI-VAMP) is an
essential protein for neurite outgrowth in PC12 cells and mediates
both axonal and dendritic outgrowth in developing neurons [29].
Interestingly, TI-VAMP is mainly localized to the Golgi apparatus
and in late endosomes/lysosomes and is involved in transportation
from the Golgi to the cell surface. Meanwhile, studies in the yeast S.
cerevisiae revealed that P4-ATPases, such as Drs2p, play a critical
role in the transport of vesicles within biogenesis pathways [6].
Thus it is reasonable to speculate that P4-ATPases family members
may be involved in neuronal differentiation through participating
vesicle transportation. ATP8A2 transport PS across cell membrane,
and it is reported that alteration of PS receptor is necessary for
proper brain development [9,30]. The patient with a disrupted
ATP8A2 gene exhibited severe neurological phenotype, including
retarded mental development, may closely relate to ATP8A2 func-
tion during neuronal differentiation [7]. Our ﬁndings indicate that
ATP8A2, possibly in synergy with CDC50A, may function through
vesicle formation/transportation to promote neurite outgrowth.As very little is known regarding the function of ATP8A2 in the ner-
vous system and its mechanism of action, our results indicate that
ATP8A2 increases axon length in hippocampal neurons.
In conclusion, our data strongly suggest an important role for
ATP8A2 acting in synergy with CDC50A in neuronal differentiation.
Our ﬁndings raise new questions about the function of P4-ATPases
in neurons and provide further support for the notion that CDC50A
proteins are vital components of the ATP8A2 machinery.
Acknowledgments
We would like to thank our colleagues Bin Liu, Rui-Ying Hu and
Zhen-Ning Zhou for helpful discussions and technical assistance.
This work was supported by Grants from the National Basic Re-
search Program of China (2009CB941103 and 2011CBA01105) to
X.D.; Grants from the Science and Technology Planning Project of
Shanghai, China (11140903400 to X.D. and 10ZR1435400 to P.X.);
Grants from the Major National Science and Technology Projects
(2011ZX09307-302-01) and Sino German cooperation project
1812 Q. Xu et al. / FEBS Letters 586 (2012) 1803–1812(GZ517) to X.D.; Grants from the National Natural Science Founda-
tion of China (31000624 to Y.L.C. and 30825013 to Z.G.L.) and the
Knowledge Innovation Program of Shanghai Institutes for Biologi-
cal Sciences (2010KIP302) to Y.L.C.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.febslet.2012.
05.018.
References
[1] van Meer, G., Voelker, D.R. and Feigenson, G.W. (2008) Membrane lipids:
where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112–124.
[2] Op den Kamp, J.A. (1979) Lipid asymmetry in membranes. Annu. Rev.
Biochem. 48, 47–71.
[3] Alder-Baerens, N., Lisman, Q., Luong, L., Pomorski, T. and Holthuis, J.C. (2006)
Loss of P4 ATPases Drs2p and Dnf3p disrupts aminophospholipid transport
and asymmetry in yeast post-Golgi secretory vesicles. Mol. Biol. Cell 17, 1632–
1642.
[4] Xu, P., Okkeri, J., Hanisch, S., Hu, R.Y., Xu, Q., Pomorski, T.G. and Ding, X.Y.
(2009) Identiﬁcation of a novel mouse P4-ATPase family member highly
expressed during spermatogenesis. J. Cell Sci. 122, 2866–2876.
[5] Bull, L.N., van Eijk, M.J., Pawlikowska, L., DeYoung, J.A., Juijn, J.A., Liao, M.,
Klomp, L.W., Lomri, N., Berger, R., Scharschmidt, B.F., Knisely, A.S., Houwen,
R.H. and Freimer, N.B. (1998) A gene encoding a P-type ATPase mutated in two
forms of hereditary cholestasis. Nat. Genet. 18, 219–224.
[6] Zhou, X. and Graham, T.R. (2009) Reconstitution of phospholipid translocase
activity with puriﬁed Drs2p, a type-IV P-type ATPase from budding yeast. Proc.
Natl. Acad. Sci. U S A 106, 16586–16591.
[7] Cacciagli, P., Haddad, M.R., Mignon-Ravix, C., El-Waly, B., Moncla, A., Missirian,
C., Chabrol, B. and Villard, L. (2010) Disruption of the ATP8A2 gene in a patient
with a t(10;13) de novo balanced translocation and a severe neurological
phenotype. Eur. J. Hum. Genet. 18, 1360–1363.
[8] Coleman, J.A., Kwok, M.C. and Molday, R.S. (2009) Localization, puriﬁcation,
and functional reconstitution of the P4-ATPase Atp8a2, a phosphatidylserine
ﬂippase in photoreceptor disc membranes. J. Biol. Chem. 284, 32670–
32679.
[9] Halleck, M.S., Lawler, J.F.J.R., Blackshaw, S., Gao, L., Nagarajan, P., Hacker, C.,
Pyle, S., Newman, J.T., Nakanishi, Y., Ando, H., Weinstock, D., Williamson, P.
and Schlegel, R.A. (1999) Differential expression of putative transbilayer
amphipath transporters. Physiol. Genomics. 1, 139–150.
[10] Saito, K., Fujimura-Kamada, K., Furuta, N., Kato, U., Umeda, M. and Tanaka, K.
(2004) Cdc50p, a protein required for polarized growth, associates with the
Drs2p P-type ATPase implicated in phospholipid translocation in
Saccharomyces cerevisiae. Mol. Biol. Cell 15, 3418–3432.
[11] Lenoir, G., Williamson, P., Puts, C.F. and Holthuis, J.C. (2009) Cdc50p plays a
vital role in the ATPase reaction cycle of the putative aminophospholipid
transporter Drs2p. J. Biol. Chem. 284, 17956–17967.
[12] Kato, U., Emoto, K., Fredriksson, C., Nakamura, H., Ohta, A., Kobayashi, T.,
Murakami-Murofushi, K., Kobayashi, T. and Umeda, M. (2002) A novel
membrane protein, Ros3p, is required for phospholipid translocation acrossthe plasma membrane in Saccharomyces cerevisiae. J. Biol. Chem. 277,
37855–37862.
[13] Katoh, Y. and Katoh, M. (2004) Identiﬁcation and characterization of CDC50A,
CDC50B and CDC50C genes in silico. Oncol. Rep. 12, 939–943.
[14] van der Velden, L.M., Wichers, C.G., van Breevoort, A.E., Coleman, J.A., Molday,
R.S., Berger, R., Klomp, L.W. and van de Graaf, S.F. (2010) Heteromeric
interactions required for abundance and subcellular localization of human
CDC50 proteins and class 1 P4-ATPases. J. Biol. Chem. 285, 40088–40096.
[15] Coleman, J.A. and Molday, R.S. (2011) Critical role of the {beta}-subunit
CDC50A in the stable expression, assembly, subcellular localization, and lipid
transport activity of the P4-ATPase ATP8A2. J. Biol. Chem. 286, 17205–17216.
[16] Chen, Y.M., Wang, Q.J., Hu, H.S., Yu, P.C., Zhu, J., Drewes, G., Piwnica-Worms, H.
and Luo, Z.G. (2006) Microtubule afﬁnity-regulating kinase 2 functions
downstream of the PAR-3/PAR-6/atypical PKC complex in regulating
hippocampal neuronal polarity. Proc. Natl. Acad. Sci. U S A 103, 8534–8539.
[17] Chen, Y.L., Liu, B., Zhou, Z.N., Hu, R.Y., Fei, C., Xie, Z.H. and Ding, X. (2009)
Smad6 inhibits the transcriptional activity of Tbx6 by mediating its
degradation. J. Biol. Chem. 284, 23481–23490.
[18] Chen, Y.L., Lv, J., Ye, X.L., Sun, M.Y., Xu, Q., Liu, C.H., Min, L.H., Li, H.P., Liu, P. and
Ding, X. (2011) Sorafenib inhibits transforming growth factor b1-mediated
epithelial-mesenchymal transition and apoptosis in mouse hepatocytes.
Hepatology 53, 1708–1718.
[19] Lou, X., Fang, P., Li, S., Hu, R.Y., Kuerner, K.M., Steinbeisser, H. and Ding, X.
(2006) Xenopus Tbx6 mediates posterior patterning via activation of Wnt and
FGF signalling. Cell Res. 16, 771–779.
[20] Karamoysoyli, E., Burnand, R.C., Tomlinson, D.R. and Gardiner, N.J. (2008)
Neuritin mediates nerve growth factor-induced axonal regeneration and is
deﬁcient in experimental diabetic neuropathy. Diabetes 57, 181–189.
[21] Zhang, X., Zhu, J., Yang, G.Y., Wang, Q.J., Qian, L., Chen, Y.M., Chen, F., Tao, Y.,
Hu, H.S., Wang, T. and Luo, Z.G. (2007) Dishevelled promotes axon
differentiation by regulating atypical protein kinase C. Nat. Cell Biol. 9, 743–
754.
[22] Vaudry, D., Stork, P.J., Lazarovici, P. and Eiden, L.E. (2002) Signaling pathways
for PC12 cell differentiation: making the right connections. Science 296, 1648–
1649.
[23] Greene, L.A. and Tischler, A.S. (1976) Establishment of a noradrenergic clonal
line of rat adrenal pheochromocytoma cells which respond to nerve growth
factor. Proc. Natl. Acad. Sci. U S A 73, 2424–2428.
[24] Xiao, J. and Liu, Y. (2003) Differential roles of ERK and JNK in early and late
stages of neuritogenesis: a study in a novel PC12 model system. J. Neurochem.
86, 1516–1523.
[25] Kühlbrandt, W. (2004) Biology, structure and mechanism of P-type ATPases.
Nat. Rev. Mol. Cell Biol. 5, 282–295.
[26] Dotti, C.G., Sullivan, C.A. and Banker, G.A. (1988) The establishment of polarity
by hippocampal neurons in culture. J. Neurosci. 8, 1454–1468.
[27] Sann, S., Wang, Z., Brown, H. and Jin, Y. (2009) Roles of endosomal trafﬁcking
in neurite outgrowth and guidance. Trends. Cell Biol. 19, 317–324.
[28] Matteoli, M., Coco, S., Schenk, U. and Verderio, C. (2004) Vesicle turnover in
developing neurons: how to build a presynaptic terminal. Trends Cell Biol. 14,
133–140.
[29] Martinez-Arca, S., Coco, S., Mainguy, G., Schenk, U., Alberts, P., Bouillé, P.,
Mezzina, M., Prochiantz, A., Matteoli, M., Louvard, D. and Galli, T. (2001) A
common exocytotic mechanism mediates axonal and dendritic outgrowth. J.
Neurosci. 21, 3830–3838.
[30] Li, M.O., Sarkisian, M.R., Mehal, W.Z., Rakic, P. and Flavell, R.A. (2003)
Phosphatidylserine receptor is required for clearance of apoptotic cells.
Science 302, 1560–1563.
